Assessing Two Coenzyme Q10 Products in Men and Women
Part of paid clinical trials in Addison, Illinois.
- Sponsor
- Midwest Center for Metabolic and Cardiovascular Research
- Study ID
- NCT07530250
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- CoQ10 Blood Levels
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- high absorption CoQ10 product — DIETARY_SUPPLEMENT100 mg CoQ10 product designed for high absorption (administered as two 50 mg capsules)
- standard CoQ10 product — DIETARY_SUPPLEMENT100 mg standard CoQ10 product (administered as two 50 mg capsules)
Study Details
The goal of this clinical trial is to compare the relative bioavailability of coenzyme Q10 (CoQ10) from acute administrations of a CoQ10 product designed for enhanced absorption versus a standard CoQ10 product in healthy men and women. Participants will be asked to come to the clinical on five different occasions, including a screening visit (visit 1, -7 days), two test 1 visits (visits 2 and 3, days 0 and 1), and two test 2 visits (visits 4 and 5, days 7 and 8). During the start of each test visit (visits 2 and 4), the participant will consume each study product with water and a standardized breakfast meal. Then, blood samples will be collected over a 10-hour period, and a standardized lunch, dinner, and snacks will be provided. The participant will return to the clinic the next morning for a blood draw 24 hours after the study product ingestion from the previous day. The same procedures will be repeated 7 to 14 days later with the other study product.
Key Dates
- Start date
- Apr 30, 2026
- Status verified
- May 2026
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- OTHER
Arms
- Experimental: Experimental - high absorption CoQ10 product100 mg CoQ10 product designed for high absorption (administered as two 50 mg capsules)
- Active Comparator: Active Comparator - standard CoQ10 product100 mg standard CoQ10 product (administered as two 50 mg capsules)
Primary Outcome Measure
Net incremental area under the curve (niAUC) for plasma CoQ10 [ Time Frame: 7 to 14 days between conditions ]
Central Contacts
- Caryn Adams, MPH6304696600
- Sara Campbell, MPH6304696600
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Biofortis Clinical Research | Addison | Illinois | 60101 |